Skip to main content
Support

In New Life, Old Bottles: Regulating First-Generation Products of Synthetic Biology, Michael Rodemeyer examines the benefits and drawbacks of using the existing U.S. regulatory framework for biotechnology to cover the new products and processes enabled by synthetic biology. The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, especially in contained laboratories and manufacturing facilities, according to the report. But further advances in this emerging field are likely to create significant challenges for U.S. government oversight.

Tagged

About the Author

Michael Rodemeyer

Read More

Science and Technology Innovation Program

The Science and Technology Innovation Program (STIP) serves as the bridge between technologists, policymakers, industry, and global stakeholders.  Read more